Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma ; volume:5 ; number:1 ; day:15 ; month:5 ; year:2017 ; pages:1-3 ; date:12.2017
Acta Neuropathologica Communications ; 5, Heft 1 (15.5.2017), 1-3, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
López, Giselle
- Beteiligte Personen und Organisationen
-
Oberheim Bush, Nancy Ann
Berger, Mitchel S.
Perry, Arie
Solomon, David A.
SpringerLink (Online service)
- DOI
-
10.1186/s40478-017-0440-x
- URN
-
urn:nbn:de:1111-201705254396
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- López, Giselle
- Oberheim Bush, Nancy Ann
- Berger, Mitchel S.
- Perry, Arie
- Solomon, David A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma
Prognostic factors analysis of diffuse midline glioma
Correction to: Prognostic factors analysis of diffuse midline glioma
Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma
A H3K27M-targeted vaccine in adults with diffuse midline glioma
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Flank Pain as a First Symptom of a Diffuse Midline Glioma
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant